Stay updated on Daratumumab Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page.

Latest updates to the Daratumumab Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page
- Check6 days agoChange DetectedThe history now includes a new revision entry v3.4.3 and removes the old entry v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page history shows a new Revision: v3.4.2 added and the funding-status notice and Revision: v3.4.1 removed; these are minor administrative updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check41 days agoChange DetectedDifference0.9%

- Check49 days agoChange DetectedUI changes include a new 'Show glossary' option and color-coded highlight explanations (green/red), along with a new revision tag 'Revision: v3.4.0' while the 'No FEAR Act data' label and the older 'Revision: v3.3.4' tag were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check56 days agoChange DetectedThe Record History adds Revision: v3.3.4 and removes Revision: v3.3.3, reflecting metadata versioning. This update does not alter study details or page functionality.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded Revision: v3.3.3 to the Record History; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.2%

Stay in the know with updates to Daratumumab Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page.